Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Taxes (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Current Taxes data on record, last reported at $5.6 million in Q3 2025.

  • For Q3 2025, Current Taxes rose 339.73% year-over-year to $5.6 million; the TTM value through Sep 2025 reached $5.6 million, up 339.73%, while the annual FY2024 figure was $9.7 million, 500.62% up from the prior year.
  • Current Taxes reached $5.6 million in Q3 2025 per AMPH's latest filing, up from $1.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $31.1 million in Q3 2023 and bottomed at $597000.0 in Q2 2022.
  • Average Current Taxes over 5 years is $7.4 million, with a median of $4.6 million recorded in 2022.
  • Peak YoY movement for Current Taxes: soared 2864.15% in 2023, then plummeted 95.88% in 2024.
  • A 5-year view of Current Taxes shows it stood at $9.1 million in 2021, then tumbled by 49.66% to $4.6 million in 2022, then crashed by 64.8% to $1.6 million in 2023, then soared by 500.62% to $9.7 million in 2024, then plummeted by 41.71% to $5.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $5.6 million in Q3 2025, $1.0 million in Q2 2025, and $15.1 million in Q1 2025.